We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Potential New Tool for Cervical Cancer Detection

By MedImaging International staff writers
Posted on 29 Dec 2014
Print article
Image: Comparison of between normal cervical tissue (top), tissue lesion (second row), photographic image (third row) and corresponding DMAP images (fourth row) (Photo courtesy of Biomedical Optics Express).
Image: Comparison of between normal cervical tissue (top), tissue lesion (second row), photographic image (third row) and corresponding DMAP images (fourth row) (Photo courtesy of Biomedical Optics Express).
Photoacoustic imaging (PAI) has the potential to be a quicker, cheaper, and less-invasive method for detecting and staging cervical cancer (CC), according to a new study.

Researchers at Central South University (Changsha, China) conducted 30 in vitro experiments with tissue samples representing different cancer stages, using PAI, a hybrid optical imaging technique that combines the high contrast of pure optical imaging with the high spatial resolution and the deep imaging depth of ultrasound. The technique involves short laser pulses, some of which are absorbed by the tissues and converted into heat, leading to rapid thermal expansion inside the tissues that produces ultrasonic waves. The generated waves are then detected by an ultrasonic sensor to form photoacoustic images of the tissues.

In each of the experiments, the researchers embedded one section of normal cervical tissue and one section of cervical lesion (from the same person) in a cylindrical phantom for simultaneous PAI. Part of each sample was also sent to histological evaluation for cross-PAI. By processing all of the imaging data, the researchers obtained a depth maximum amplitude projection (DMAP) image, which shows the PAI contrast of the sample. The researchers used hemoglobin as the contrast agent, since PAI is highly sensitive to abnormal angiogenesis, a hallmark of CC tumors.

The obtained DMAP images were analyzed to evaluate the extent of the angiogenesis for different clinical stages of CC. The results showed stronger absorption from the cervical lesions, relative to that of normal tissue. The difference in mean optical absorption (MOA) between normal tissue and CC lesions showed a statistical significance, and the MOA of the CC lesions were closely related to the severity of CC. The study was published in the January 2015 issue of Biomedical Optics Express.

“Due to the higher hemoglobin concentration, abnormal angiogenesis has higher optical absorptions in certain wavelengths than normal tissues,” said lead author assistant professor of biomedical engineering Jiaying Xiao, PhD. “The technique is noninvasive and can detect the lesions in the cervical canal, an area conventional methods fail to observe. The photoacoustic imaging can also evaluate the invasion depth of cervical lesions more effectively.”

In current clinical practice, the diagnosis of CC is mainly through the cervical screening followed by a necessary biopsy, but this method is labor consuming and expensive, and can only detect superficial lesions around the external cervical orifice. In contrast, PAI is sensitive to the abnormal angiogenesis deep in the biological tissue, and may be capable for the intact scanning both around the external orifice and in cervical canal.

Related Links:

Central South University


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Enterprise Imaging & Reporting Solution
Syngo Carbon
Thyroid Shield
Standard Thyroid Shield
Color Doppler Ultrasound System
DRE Crystal 4PX

Print article

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The multi-spectral optoacoustic tomography (MSOT) machine generates images of biological tissues (Photo courtesy of University of Missouri)

New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure

Imaging inflammation using traditional radiological techniques presents significant challenges, including radiation exposure, poor image quality, high costs, and invasive procedures. Now, new contrast... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.